3 news items
Outdoing Cancer Requires Pharma To Go Beyond Merely Revolutionizing Existing Treatment
MRK
MRNA
MYNZ
22 Feb 24
is one of the most complex diseases in human history, a battle that pharma still hasn’t won. Pfizer made it its mission to outdo cancer, so did its
Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032
ABBV
LLY
MRK
15 Feb 24
and their families is underscored by the results observed in this Phase 3 trial, representing a step forward in our mission to bring more hope to Canadians
Health Canada Approves KEYTRUDA® in combination with trastuzumab and chemotherapy, as a first-line treatment for patients with locally advanced unresectable or metastatic HER2-positive gastric or gastroesophageal junction adenocarcinoma whose tumours express PD-L1 (CPS ≥ 1)
MRK
12 Feb 24
forward in our mission to bring more hope to Canadians impacted by this challenging disease
- Prev
- 1
- Next